Anti-Myelin Oligodendrocyte Glycoprotein Optic Neuritis or Neuroretinitis?
Publication
, Journal Article
Lee, AR; El-Dairi, MA
Published in: JAMA Ophthalmol
October 1, 2018
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JAMA Ophthalmol
DOI
EISSN
2168-6173
Publication Date
October 1, 2018
Volume
136
Issue
10
Start / End Page
e182928
Location
United States
Related Subject Headings
- Visual Acuity
- Tomography, Optical Coherence
- Rituximab
- Retinitis
- Optic Neuritis
- Ophthalmology & Optometry
- Myelin-Oligodendrocyte Glycoprotein
- Infusions, Intravenous
- Immunologic Factors
- Humans
Citation
APA
Chicago
ICMJE
MLA
NLM
Lee, A. R., & El-Dairi, M. A. (2018). Anti-Myelin Oligodendrocyte Glycoprotein Optic Neuritis or Neuroretinitis? JAMA Ophthalmol, 136(10), e182928. https://doi.org/10.1001/jamaophthalmol.2018.2928
Lee, Andrew R., and Mays A. El-Dairi. “Anti-Myelin Oligodendrocyte Glycoprotein Optic Neuritis or Neuroretinitis?” JAMA Ophthalmol 136, no. 10 (October 1, 2018): e182928. https://doi.org/10.1001/jamaophthalmol.2018.2928.
Lee AR, El-Dairi MA. Anti-Myelin Oligodendrocyte Glycoprotein Optic Neuritis or Neuroretinitis? JAMA Ophthalmol. 2018 Oct 1;136(10):e182928.
Lee, Andrew R., and Mays A. El-Dairi. “Anti-Myelin Oligodendrocyte Glycoprotein Optic Neuritis or Neuroretinitis?” JAMA Ophthalmol, vol. 136, no. 10, Oct. 2018, p. e182928. Pubmed, doi:10.1001/jamaophthalmol.2018.2928.
Lee AR, El-Dairi MA. Anti-Myelin Oligodendrocyte Glycoprotein Optic Neuritis or Neuroretinitis? JAMA Ophthalmol. 2018 Oct 1;136(10):e182928.
Published In
JAMA Ophthalmol
DOI
EISSN
2168-6173
Publication Date
October 1, 2018
Volume
136
Issue
10
Start / End Page
e182928
Location
United States
Related Subject Headings
- Visual Acuity
- Tomography, Optical Coherence
- Rituximab
- Retinitis
- Optic Neuritis
- Ophthalmology & Optometry
- Myelin-Oligodendrocyte Glycoprotein
- Infusions, Intravenous
- Immunologic Factors
- Humans